文献速递冠心病外科

微创冠状动脉旁路移植术后566例患者血运重建分析

Revascularization after minimally invasive coronary artery bypass grafting in 566 patients: Is it a problem?
PubMed 文献 · J Thorac Cardiovasc Surg · 2024-11-25

OBJECTIVES: Minimally invasive coronary artery bypass grafting (MICS CABG) allows visualization and revascularization of all myocardial territories through a small anterolateral thoracotomy, with or without cardiopulmonary bypass.…

要点

  • 微创冠脉搭桥后再次血运重建发生率低(8.7%),12年累积发生率14.8±2.5%。
  • 围术期输血是再次血运重建的唯一相关因素(HR 5.0,95%CI 2.4-10.3)。

核心结论

  • 微创冠脉搭桥术后再次血运重建发生率低,且未对远期生存造成负面影响。

研究设计与样本

  • 单中心前瞻性队列研究,纳入17年间接受微创冠脉搭桥的566例患者,每年或每半年随访。

主要发现

  • 再次血运重建最常见指征为自体冠状动脉病变进展,占23例(46.9%)。
  • 围术期输血与再次血运重建相关(HR 5.0,95%CI 2.4-10.3)。

临床怎么用

  • 微创冠脉搭桥术后应关注围术期输血患者,其再次血运重建风险较高。
  • 再次血运重建不必过度担忧远期生存影响,可按常规指征进行。

局限性

  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Minimally invasive coronary artery bypass grafting (MICS CABG) allows visualization and revascularization of all myocardial territories through a small anterolateral thoracotomy, with or without cardiopulmonary bypass. It is increasing in popularity as a safe and effective alternative to sternotomy CABG. In this study, we examined the correlates and long-term outcomes of repeat revascularization (RR) in patients who undergo MICS CABG. METHODS: We prospectively followed all patients on an annual or semiannual basis who had undergone MICS CABG surgery over a 17-year period at a single institution. Cumulative incidence of RR was calculated accounting for competing risk of mortality. Kaplan-Meier curves were compared with log-rank test for survival and freedom from cardiac death at 12-years for both groups. Multivariable Cox proportional hazard models were performed to identify variables associated with RR and its impact on long-term survival. RESULTS: Clinical follow-up was complete for 100% of patients (N = 566) at a mean of 7.0 ± 4.4 years. Forty-nine (8.7%) patients required RR after their MICS CABG, for a cumulative incidence at 12 years of 14.8 ± 2.5%. The most common indication was progression of native coronary disease in 23 (46.9% of RR) patients. Perioperative transfusion was the only variable associated with RR (hazard ratio, 5.0; 95% confidence interval, 2.4-10.3). When we compared patients who had RR with those who did not, there was no significant difference in late survival (92.1 ± 4.5% vs 80.3 ± 3.0%; P = .18). CONCLUSIONS: Among 566 patients who underwent MICS CABG over a 17-year period, RR was an infrequent event affecting 8.7% of patients, with no negative impact on long-term survival.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Toubar O, Guo MH, Ashenhurst C, et al. Revascularization after minimally invasive coronary artery bypass grafting in 566 patients: Is it a problem? J Thorac Cardiovasc Surg. 2024. PMID: 39603492. doi:10.1016/j.jtcvs.2024.11.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。